Navigation Links
OpenQ is Awarded Prestigious Life Sciences Industry Award
Date:6/15/2009

OpenQ wins the 2009 Global Pharmaceutical CRM Growth Strategy Leadership of the Year presented by Frost & Sullivan

Charlottesville, VA, New York, NY and Paris, France (PRWEB) June 15, 2009 -- OpenQ, one of the industry leaders in KOL management solutions and MSL performance tools, announces that it has received the prestigious 2009 Global Pharmaceutical CRM Growth Strategy Leadership of the Year award, presented by Frost & Sullivan to the company that has demonstrated an exceptional growth strategy within the industry.

A recipient is chosen to receive the Frost & Sullivan Award for CRM Growth Strategy Leadership of the Year based on specific criteria. Through primary and secondary research methods, all companies' market revenues are tracked and those exhibiting significant growth are noted for their strategy implementation. Revenues are then compared year to year to monitor growth patterns. When a company consistently shows high growth rates, it is a candidate for the Frost & Sullivan Award Growth Strategy Leadership of the Year.

This accolade is given to the company that has bolstered their position in the market during the base year and whose strategy will have a profound and lasting impact on the market. The award criteria consist of the following:

 
  • Ability to grow in a saturated or maturing market
  • Implementing a unique sales strategy
  • Technological innovation and leadership
  • Discovering new venues for an established product
  • Effective Internet strategy
  • Strategic mergers, acquisitions, or joint ventures to penetrate new markets
  • Reorganization structured around growth strategy

About openQ:
OpenQ provides the integrated insights and software solutions to meet the critical compliance, KOL, content and speaker needs facing Life Science companies, from development stage through maturity. Achieving another year of exponential growth, openQ serves its customers from various locations across North America, South America, Europe and Asia. OpenQ's growing list of customers includes 7 of the Top 10 pharmaceutical and 3 of the Top 5 medical device companies. For more information, visit http://www.openq.com.

###

Read the full story at http://www.prweb.com/releases/2009/06/prweb2530554.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. DNA2.0 Awarded US Patents for Breakthrough Gene Optimization Technology -- Company's Unique Algorithm Enables Expression Yields up to 50 Times Greater than Competing Approaches
2. Proplant Awarded Qatar Project
3. Plexus Awarded Development Contract With QIAGEN
4. Enerkem GreenField Alberta Biofuels Awarded Permit to Build Worlds First Commercial Municipal Waste-to-Biofuels Facility
5. ChanTest Awarded $4.8 Million Through the Ohio Third Frontier Research and Commercialization Program
6. CeNeRx BioPharma Awarded New Patent for its Innovative Compounds That Selectively Target Peripheral Cannabinoid Receptors
7. ArunA Biomedical Awarded Department of Defense Contract to Further Develop Environmental Biosensor for National Security
8. Peregrine Pharmaceuticals Awarded New U.S. Patent Further Strengthening Its Anti-Phospholipid Patent Portfolio
9. PCI Biotech-led Consortium Awarded EUR1.1 m Eurostars Grant for siRNA
10. Transgenomic Awarded Clinical Laboratory Certification in California
11. OLIGOMERIX Awarded NIH Grant to Develop Novel Biomarkers for Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
OpenQ is Awarded Prestigious Life Sciences Industry Award
(Date:3/24/2017)... 2017 Research and Markets has announced the ... Global Strategic Business Report" report to their offering. ... This report analyzes the ... Million. Annual estimates and forecasts are provided for the period 2014 ... secondary research. The report profiles 25 companies including ...
(Date:3/24/2017)... , March 24, 2017 Agenus Inc. ... immune checkpoint antibodies and cancer vaccines, today announced participation ... 7 th  Annual William Blair and Maidstone Life Sciences ... Alexandria Center in New York, NY ... March 29 at 9:40 am: Robert B. ...
(Date:3/23/2017)... March 23, 2017  Northwest Biotherapeutics (OTCQB: NWBO) ... immune therapies for solid tumor cancers, today announced ... financing it announced last Friday, March 17, 2017. ... institutional investors securities totaling 28,843,692 shares, comprised of ... 10,000,000 shares of Class C Warrants pre-funded at ...
(Date:3/23/2017)... CT (PRWEB) , ... March 23, 2017 , ... ... LLC, was recently selected by the Connecticut Technology Council (CTC) as a 2017 ... at CTC’s thirteenth annual Women of Innovation Awards Dinner. , The dinner recognizes ...
Breaking Biology Technology:
(Date:2/24/2017)...  EyeLock LLC, a leader of iris-based identity ... biometric solution on the latest Qualcomm® Snapdragon™ 835 ... World Congress 2017 (February 27 – March ... 3, Stand 3E10. The Snapdragon ... platform—a combination of hardware, software and biometrics ...
(Date:2/16/2017)... FRANCISCO , Feb. 16, 2017  Genos, ... today announced that it has received Laboratory Accreditation ... CAP Accreditation is presented to laboratories that meet ... who demonstrate scientifically rigorous processes. "Genos ... excellence in laboratory practices. We,re honored to be ...
(Date:2/10/2017)... , Feb 10, 2017 Research ... report "Personalized Medicine - Scientific and Commercial Aspects" ... ... medicine. Diagnosis is integrated with therapy for selection of treatment ... early detection and prevention of disease in modern medicine. Biochip/microarray ...
Breaking Biology News(10 mins):